Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > AGM date has moved - ask why

<< Previous

Bullboard Posts

Next >>

Comment by MirrorWorldManon Oct 31, 2022 5:24pm

98 Views

Post# 35061372

RE:RE:RE:RE:AGM date has moved - ask why

Any roll back needs to be accompanied with a simultaneous announcement of a cap on outstanding shares. Otherwise, Howie will just dilute that into oblivion again...

<< Previous

Bullboard Posts

Next >>

Junior helium stock to benefit from new legislation in U.S.